Serene is pleased to announce that it has completed the enrollment of a pivotal trial of its lead product, Synovetin OA, in a trial of naturally occurring canine elbow osteoarthritis. Synovetin OA is a proprietary Sn-117m colloid used for the…
Serene, LLC was the featured company profile in the "My Biz in Isotopes" section of the February 2017 Newsletter edition.
Serene's commercial manufacturing facility located at Theragenics Corporation is completing processes and procedures to supply Synovetin OA. Validations currently underway will be completed within the next few weeks in time to support all future trials and commercial demands.